| Intranasal administration as a route for drug delivery to the brain: evidence for a unique pathway for albumin JA Falcone, TS Salameh, X Yi, BJ Cordy, WG Mortell, AV Kabanov, ... Journal of Pharmacology and Experimental Therapeutics 351 (1), 54-60, 2014 | 82 | 2014 |
| Disruption of the hippocampal and hypothalamic blood–brain barrier in a diet-induced obese model of type II diabetes: prevention and treatment by the mitochondrial carbonic … TS Salameh, WG Mortell, AF Logsdon, DA Butterfield, WA Banks Fluids and Barriers of the CNS 16, 1-17, 2019 | 77 | 2019 |
| 1958-P: Role of Leptin in Blood-Brain Barrier Dysfunction TS Salameh, W Mortell, WA Banks Diabetes 68 (Supplement_1), 2019 | 1 | 2019 |
| Resistin Is Associated with Blood-Brain Barrier Disruption in Mice Resistant to Diet-Induced Obesity and Treated with Topiramate TS SALAMEH, W MORTELL, WA BANKS Diabetes 67 (Supplement_1), 2018 | 1 | 2018 |
| Brain microvascular complications occur in high-fat fed hyperglycemic and not euglycemic mice: role of the gut microbiome TS Salameh, WG Mortell, WA Banks JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 39, 56-57, 2019 | | 2019 |
| Abstract# 3152 Blood–brain barrier disruption in animal models of Type I and Type II diabetes: The role of insulin and leptin TS Salameh, WG Mortell, WA Banks Brain, Behavior, and Immunity 76, e30, 2019 | | 2019 |
| Blood-Brain Barrier Disruption in a Diet-Induced Obese Model of Type 2 Diabetes: Treatment with the Mitochondrial Anhydrase Inhibitor Topiramate TS Salameh, WG Mortell, CA Dickson, WA Banks DIABETES 66, A548-A548, 2017 | | 2017 |
